- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- April 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 173 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- April 2025
Germany, Italy, Japan, ... Germany, Italy, Japan, Spain, Europe
From €6550EUR$7,500USD£5,690GBP
- Report
- April 2025
United States
From €2183EUR$2,500USD£1,897GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 150 Pages
Global
From €2489EUR$2,850USD£2,162GBP
€3362EUR$3,850USD£2,921GBP
- Report
- July 2023
- 130 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- February 2024
- 179 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- April 2023
- 120 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- November 2022
- 140 Pages
Europe
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 131 Pages
Middle East, Africa
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 140 Pages
Asia Pacific
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 124 Pages
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 128 Pages
North America
From €3013EUR$3,450USD£2,617GBP
- Report
- July 2022
- 183 Pages
Global
From €3886EUR$4,450USD£3,376GBP
- Report
- February 2024
- 124 Pages
Global
From €2969EUR$3,400USD£2,579GBP
€3712EUR$4,250USD£3,224GBP
- Report
- June 2023
- 115 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- July 2024
- 158 Pages
Global
From €3155EUR$3,613USD£2,741GBP
€3712EUR$4,250USD£3,224GBP

The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings.
The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests.
Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more